"Proton Pump Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX.
| Descriptor ID |
D054328
|
| MeSH Number(s) |
D27.505.519.389.848
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Proton Pump Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Proton Pump Inhibitors".
This graph shows the total number of publications written about "Proton Pump Inhibitors" by people in this website by year, and whether "Proton Pump Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 2 | 2 | 4 |
| 1999 | 2 | 3 | 5 |
| 2000 | 1 | 3 | 4 |
| 2001 | 6 | 2 | 8 |
| 2002 | 3 | 3 | 6 |
| 2003 | 2 | 1 | 3 |
| 2004 | 3 | 5 | 8 |
| 2005 | 6 | 2 | 8 |
| 2006 | 5 | 3 | 8 |
| 2007 | 5 | 1 | 6 |
| 2008 | 4 | 2 | 6 |
| 2009 | 4 | 6 | 10 |
| 2010 | 7 | 2 | 9 |
| 2011 | 6 | 3 | 9 |
| 2012 | 5 | 5 | 10 |
| 2013 | 7 | 6 | 13 |
| 2014 | 5 | 3 | 8 |
| 2015 | 16 | 5 | 21 |
| 2016 | 8 | 4 | 12 |
| 2017 | 12 | 5 | 17 |
| 2018 | 11 | 5 | 16 |
| 2019 | 8 | 4 | 12 |
| 2020 | 12 | 5 | 17 |
| 2021 | 3 | 1 | 4 |
| 2022 | 1 | 9 | 10 |
| 2023 | 1 | 6 | 7 |
| 2024 | 5 | 5 | 10 |
| 2025 | 2 | 4 | 6 |
| 2026 | 3 | 3 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proton Pump Inhibitors" by people in Profiles.
-
Controversies in management of Helicobacter pylori infection from a U.S. perspective: population screening and treatment. Minerva Gastroenterol (Torino). 2025 Sep; 71(3):194-206.
-
Clinical implications of combination proton pump inhibitor and triple therapies in patients with atrial fibrillation following percutaneous intervention: a guide for clinicians. Expert Rev Cardiovasc Ther. 2024 Sep; 22(9):483-491.
-
The role of transoral incisionless fundoplication (TIF) in the management of gastroesophageal reflux disease (GERD) following peroral endoscopic myotomy (POEM): A pilot, prospective, patient-driven study. Saudi J Gastroenterol. 2024 07 01; 30(4):266-271.
-
Controversies regarding management of Helicobacter pylori infections. Curr Opin Gastroenterol. 2023 11 01; 39(6):482-489.
-
Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study. Front Immunol. 2022; 13:1049908.
-
Recent Developments Pertaining to H. pylori Infection. Am J Gastroenterol. 2021 01 01; 116(1):1-3.
-
Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection? Am J Gastroenterol. 2020 11; 115(11):1920-1921.
-
Proton pump inhibitors do not increase the risk of dementia: a systematic review and meta-analysis of prospective studies. Dis Esophagus. 2020 Oct 12; 33(10).
-
Is it time to revisit surgery and endoscopic therapy for refractory GERD? Gastrointest Endosc. 2020 07; 92(1):88-90.
-
Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients. Dig Dis Sci. 2020 09; 65(9):2691-2699.